Cargando…
Polio by the Numbers—A Global Perspective( )
BACKGROUND: Investments in national immunization programs and the Global Polio Eradication Initiative (GPEI) have resulted in substantial reductions in paralytic polio worldwide. However, cases prevented because of investments in immunization programs and GPEI remain incompletely characterized. METH...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556648/ https://www.ncbi.nlm.nih.gov/pubmed/35415741 http://dx.doi.org/10.1093/infdis/jiac130 |
_version_ | 1784807108842094592 |
---|---|
author | Badizadegan, Kamran Kalkowska, Dominika A Thompson, Kimberly M |
author_facet | Badizadegan, Kamran Kalkowska, Dominika A Thompson, Kimberly M |
author_sort | Badizadegan, Kamran |
collection | PubMed |
description | BACKGROUND: Investments in national immunization programs and the Global Polio Eradication Initiative (GPEI) have resulted in substantial reductions in paralytic polio worldwide. However, cases prevented because of investments in immunization programs and GPEI remain incompletely characterized. METHODS: Using a global model that integrates polio transmission, immunity, and vaccine dynamics, we provide estimates of polio incidence and numbers of paralytic cases prevented. We compare the results with reported cases and estimates historically published by the World Health Organization. RESULTS: We estimate that the existence and use of polio vaccines prevented 5 million cases of paralytic polio for 1960–1987 and 24 million cases worldwide for 1988–2021 compared to a counterfactual world with no polio vaccines. Since the 1988 resolution to eradicate polio, our estimates suggest GPEI prevented 2.5–6 million cases of paralytic polio compared to counterfactual worlds without GPEI that assume different levels of intensity of polio vaccine use in routine immunization programs. CONCLUSIONS: Analysis of historical cases provides important context for understanding and communicating the benefits of investments made in polio eradication. Prospective studies will need to explore the expected benefits of future investments, the outcomes of which will depend on whether and when polio is globally eradicated. |
format | Online Article Text |
id | pubmed-9556648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95566482022-10-19 Polio by the Numbers—A Global Perspective( ) Badizadegan, Kamran Kalkowska, Dominika A Thompson, Kimberly M J Infect Dis Major Article BACKGROUND: Investments in national immunization programs and the Global Polio Eradication Initiative (GPEI) have resulted in substantial reductions in paralytic polio worldwide. However, cases prevented because of investments in immunization programs and GPEI remain incompletely characterized. METHODS: Using a global model that integrates polio transmission, immunity, and vaccine dynamics, we provide estimates of polio incidence and numbers of paralytic cases prevented. We compare the results with reported cases and estimates historically published by the World Health Organization. RESULTS: We estimate that the existence and use of polio vaccines prevented 5 million cases of paralytic polio for 1960–1987 and 24 million cases worldwide for 1988–2021 compared to a counterfactual world with no polio vaccines. Since the 1988 resolution to eradicate polio, our estimates suggest GPEI prevented 2.5–6 million cases of paralytic polio compared to counterfactual worlds without GPEI that assume different levels of intensity of polio vaccine use in routine immunization programs. CONCLUSIONS: Analysis of historical cases provides important context for understanding and communicating the benefits of investments made in polio eradication. Prospective studies will need to explore the expected benefits of future investments, the outcomes of which will depend on whether and when polio is globally eradicated. Oxford University Press 2022-04-13 /pmc/articles/PMC9556648/ /pubmed/35415741 http://dx.doi.org/10.1093/infdis/jiac130 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Major Article Badizadegan, Kamran Kalkowska, Dominika A Thompson, Kimberly M Polio by the Numbers—A Global Perspective( ) |
title | Polio by the Numbers—A Global Perspective( ) |
title_full | Polio by the Numbers—A Global Perspective( ) |
title_fullStr | Polio by the Numbers—A Global Perspective( ) |
title_full_unstemmed | Polio by the Numbers—A Global Perspective( ) |
title_short | Polio by the Numbers—A Global Perspective( ) |
title_sort | polio by the numbers—a global perspective( ) |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556648/ https://www.ncbi.nlm.nih.gov/pubmed/35415741 http://dx.doi.org/10.1093/infdis/jiac130 |
work_keys_str_mv | AT badizadegankamran poliobythenumbersaglobalperspective AT kalkowskadominikaa poliobythenumbersaglobalperspective AT thompsonkimberlym poliobythenumbersaglobalperspective |